COCH (Envoy Medical) Inventories, Finished Goods : $0.12 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Envoy Medical Inventories, Finished Goods?

Envoy Medical's quarterly finished goods increased from Jun. 2024 ($0.08 Mil) to Sep. 2024 ($0.13 Mil) but then declined from Sep. 2024 ($0.13 Mil) to Dec. 2024 ($0.12 Mil).

Envoy Medical's annual finished goods declined from Dec. 2022 ($0.12 Mil) to Dec. 2023 ($0.08 Mil) but then increased from Dec. 2023 ($0.08 Mil) to Dec. 2024 ($0.12 Mil).

Envoy Medical Inventories, Finished Goods Historical Data

The historical data trend for Envoy Medical's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envoy Medical Inventories, Finished Goods Chart

Envoy Medical Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Inventories, Finished Goods

0.14

0.12

0.08

0.12

Envoy Medical Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Inventories, Finished Goods	Get a 7-Day Free Trial							0.08	0.11	0.08	0.13	0.12

Envoy Medical Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Envoy Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envoy Medical Inc (NAS:COCH) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

N/A

Address

4875 White Bear Parkway, White Bear Lake, MN, USA, 55110

Website

https://www.envoymedical.com

Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.